Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ; PRECISE 2 Study Investigators. Schreiber S, et al. Among authors: thomsen oo. N Engl J Med. 2007 Jul 19;357(3):239-50. doi: 10.1056/NEJMoa062897. N Engl J Med. 2007. PMID: 17634459 Free article. Clinical Trial.
Diagnosis and management of fistulizing Crohn's disease.
Nielsen OH, Rogler G, Hahnloser D, Thomsen OØ. Nielsen OH, et al. Among authors: thomsen oo. Nat Clin Pract Gastroenterol Hepatol. 2009 Feb;6(2):92-106. doi: 10.1038/ncpgasthep1340. Epub 2009 Jan 20. Nat Clin Pract Gastroenterol Hepatol. 2009. PMID: 19153563 Review.
Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease: post hoc analysis of a randomized controlled trial.
Steenholdt C, Bendtzen K, Brynskov J, Thomsen OØ, Ainsworth MA. Steenholdt C, et al. Among authors: thomsen oo. Am J Gastroenterol. 2014 Jul;109(7):1055-64. doi: 10.1038/ajg.2014.106. Epub 2014 May 6. Am J Gastroenterol. 2014. PMID: 24796769 Clinical Trial.
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trial.
Steenholdt C, Brynskov J, Thomsen OØ, Munck LK, Fallingborg J, Christensen LA, Pedersen G, Kjeldsen J, Jacobsen BA, Oxholm AS, Kjellberg J, Bendtzen K, Ainsworth MA. Steenholdt C, et al. Among authors: thomsen oo. Gut. 2014 Jun;63(6):919-27. doi: 10.1136/gutjnl-2013-305279. Epub 2013 Jul 22. Gut. 2014. PMID: 23878167 Clinical Trial.
80 results